ArticleInternational journal of retina and vitreous2021

Safety and efficacy of Razumab™ (world's first biosimilar ranibizumab) in wet age-related macular degeneration: a post-marketing, prospective ASSET study.

Shashikant Sharma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.